The efficacy and safety of CAR-T cell therapy in patients with refractory ALL and concomitant HBV infection

被引：0
|
作者：
Peilong Lai
Xiaomei Chen
Le Qin
Zhiwu Jiang
Chenwei Luo
Xin Huang
Sujing Wu
Wei Ling
Yulian Wang
Jinghua Wang
Chenxin Deng
Lisi Huang
Lingji Zeng
Zesheng Lu
Liye Zhong
Pengjun Liao
Minming Li
Dongmei Chen
Suxia Geng
Ping Wu
Zhaoyang Tang
Duanqing Pei
Xin Du
Peng Li
Jianyu Weng
机构：
[1] Guangdong Academy of Medical Sciences,Department of Hematology, Guangdong Provincial People’s Hospital
[2] University of Chinese Academy of Sciences,State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health
[3] Chinese Academy of Sciences,Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, South China Institute for Stem Cell Biology and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health
[4] University of Chinese Academy of Sciences,undefined
[5] Chinese Academy of Sciences,undefined
[6] Guangdong Zhaotai InVivo Biomedicine Co. Ltd,undefined
来源：
Leukemia | 2020年 / 34卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2790 / 2793
页数：3
相关论文
共 50 条
  • [41] Safety and efficacy of B7-H3 targeting CAR-T cell therapy for patients with recurrent GBM
    Zhang, Yang
    Feng, Rui
    Chi, Xiaohan
    Xian, Na
    Chen, Xianzhen
    Huang, Na
    Zhang, Yu
    Zhang, Kangna
    Zhang, Jindong
    Chen, Lieping
    Ji, Nan
    Huang, Gangxiong
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [42] FIRST EVIDENCE FOR EFFICACY OF CAR-T CELL TREATMENT IN REFRACTORY ANTISYNTHETASE SYNDROME
    Taubmann, J.
    Mueller, F.
    Boeltz, S.
    Knitza, J.
    Voelkl, S.
    Aigner, M.
    Kleyer, A.
    Minnopoulou, I.
    Locatelli, F.
    D'agostino, M. A.
    Gary, R.
    Krestchmann, S.
    Kharboutli, S.
    Mougiakakos, D.
    Kroenke, G.
    Andreas, M.
    Schett, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 957 - 958
  • [43] CAR-T CELL THERAPY FOR CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH ALL
    Kato, Itaru
    PEDIATRIC BLOOD & CANCER, 2024, 71 : S6 - S6
  • [44] B cell lineage reconstitution underlies CAR-T cell therapeutic efficacy in patients with refractory myasthenia gravis
    Tian, Dai-Shi
    Qin, Chuan
    Dong, Ming-Hao
    Heming, Michael
    Zhou, Luo-Qi
    Wang, Wen
    Cai, Song-Bai
    You, Yun-Fan
    Shang, Ke
    Xiao, Jun
    Wang, Di
    Li, Chun-Rui
    Zhang, Min
    Bu, Bi-Tao
    Meyer zu Hoerste, Gerd
    Wang, Wei
    EMBO MOLECULAR MEDICINE, 2024, 16 (04) : 966 - 987
  • [45] Subsequent Secondary CAR-T Cell Therapy Was Superior to Chemotherapy in Patients with Refractory/Relapsed BCell Lymphoma after Failure of Anti-CD19 CAR-T Cell Therapy
    Yang, Fan
    Liu, Rui
    Xu, Teng
    Zheng, Peihao
    Feng, Shaomei
    Guo, Yuelu
    Ma, Lixia
    Shi, Hui
    Deng, Biping
    Ke, Xiaoyan
    Wu, Tong
    Hu, Kai
    BLOOD, 2022, 140 : 10384 - 10385
  • [46] Efficacy of anti-CD19 CAR-T cell therapy in 10 refractory recurrent B cell malignancies
    包芳
    China Medical Abstracts (Internal Medicine), 2018, 35 (03) : 186 - 187
  • [47] Biomarkers for CAR-T Cell Therapy
    不详
    TRANSFUSIONSMEDIZIN, 2024, 14 (03) : 123 - 124
  • [48] CAR-T CELL TREATMENT OF REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS- SAFETY AND PRELIMINARY EFFICACY DATA FROM THE FIRST FOUR PATIENTS
    Schett, G.
    Boeltz, S.
    Mueller, F.
    Kleyer, A.
    Voelkl, S.
    Aigner, M.
    Gary, R.
    Kretschmann, S.
    Simon, D.
    Kharboutli, S.
    Mougiakakos, D.
    Kroenke, G.
    Andreas, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 185 - 185
  • [49] CAR-T Cell Therapy and Beyond
    Dotti, Gianpietro
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S4 - S4
  • [50] LONG TERM SAFETY AND EFFICACY OF CAR-T CELL TREATMENT IN REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS - DATA FROM THE FIRST SEVEN PATIENTS
    Taubmann, J.
    Mueller, F.
    Boeltz, S.
    Voelkl, S.
    Aigner, M.
    Kleyer, A.
    Minnopoulou, I.
    Locatelli, F.
    D'agostino, M. A.
    Gary, R.
    Krestchmann, S.
    Kharboutli, S.
    Mougiakakos, D.
    Kroenke, G.
    Andreas, M.
    Schett, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 93 - 94
12345